Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P02794 (
ferritin
)
17,525
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum and tissue ferritins were quantitated by a radioimmunoassay kit (SPAC KIT, Daiichi Radioisotope Lab.) and a diagnostic implication of serum ferritins in patients with gynecological diseases was evaluated. In order to investigate the potential use of tumor marker as a feto-placental antigen (protein),
ferritin
from ovarian cancer was compared with ferritins from normal adult and feto-placental organs. Serum
ferritin
levels were significantly higher (p less than 0.01) in patients with ovarian adenocarcinoma, Krukenberg's tumor,
cervical squamous cell carcinoma
and other malignant diseases than in normal women. Among adult organs the kidney and spleen showed the highest and the heart the lowest
ferritin
content. The
ferritin
contents of the kidney and spleen were 78.4 micrograms and 76.2 micrograms/g wet weight, respectively and that of the heart was 5.7 micrograms/g wet weight. The
ferritin
contents of other adult organs ranged from 10 to 25 micrograms/g wet weight. On the other hand the placenta showed the highest and the heart and stomach the lowest
ferritin
content among feto-placental organs. The
ferritin
content of the placenta was 7 micrograms/g wet weight. The
ferritin
contents of other fetal organs were only half as in the placenta. The
ferritin
contents of ovarian cancers ranged 6 to 8 micrograms/g wet weight and was almost identical to that of the placenta.
...
PMID:[Gynecological cancer and ferritin--a study on the carcinofetoplacental ferritin]. 682 63
This study was designed to investigate the usefulness of serum
ferritin
determinations for the diagnosis of
cervical squamous cell carcinoma
. The origin of
ferritin
in the circulation of these patients was also studied by an in vitro incubation system. Ferritin levels were determined by a radioimmunoassay kit (SPAC kit, Daiichi Radioisotope Lab.). Pretreatment serum
ferritin
levels were significantly higher (p less than 0.05) in patients with
cervical squamous cell carcinoma
, ovarian carcinoma, hepatitis and anemia than in normal women. All cases with endometrian cancer showed normal
ferritin
levels. Among patients with
cervical squamous cell carcinoma
, stage IV and recurrence groups showed higher
ferritin
levels than other stages. In vitro incubation studies revealed that squamous cell carcinoma could release significantly larger amount of
ferritin
than normal squamous epithelium. In addition, circulating and tissue
ferritin
of squamous cell carcinoma had the same immunological behavior in a
ferritin
radioimmunoassay, and also showed the identical localization on isoelectrofocusing gels. These results indicated that (1) circulating
ferritin
in patients with squamous cell carcinoma would, at least in part, be derived from the tumor tissue, and (2) serum
ferritin
determinations would be useful for the management of patients with
cervical squamous cell carcinoma
.
...
PMID:[Ferritin levels in patients with cervical squamous cell carcinoma (author's transl)]. 723 35